Most SA sunblock products ‘can’t take the heat’, tests show by Bateman, Chris
778  October 2012, Vol. 102, No. 10  SAMJ
Izindaba
South African sunscreen manufacturers 
are hastily reformulating their products 
following confidential tests commissioned 
by the National Cancer Association of 
South Africa (CANSA) which show that 
most offer sub-optimal protection. This 
means that outdoor lovers (especially those 
in the Western Cape, where the incidence 
of malignant melanoma has trebled over 
the past 20 years), will face at least another 
summer using mostly below-par sunblock 
creams. Those who don’t know that most 
locally sold creams don’t offer decent 
protection beyond two hours of exposure 
to sunlight, will remain vulnerable.
In a story broken by the investigative 
weekly Noseweek this August, Cansa 
confirmed having asked a local company, 
Future Cosmetics, to test a 10% sample 
of the 357 individual sunscreen products 
sold locally (which included the three 
brand leaders) last September (2011). The 
sample came up well short of the optimal 
current internationally recommended (gold 
standard) protection. The not-for-profit 
NGO was anxious to see how the locally 
sold products fared when measured against 
the latest European Union (EU) standard, 
given the rise in malignant melanoma which 
is responsible for a full five per cent of all 
cancer deaths in South Africa.
About a decade ago it was discovered 
that UVA rays, in conjunction with UVB 
rays, were far more harmful than originally 
thought. UVA is still legally permitted in 
tanning salons using tanning beds across the 
country – in apparent complete ignorance of 
the latest research.
The now five-year-old EU standard is 
centered on the improved ‘Colipa’ test and 
measures the breakdown of the sunscreen 
over time under irradiation. Some local 
products require the UVA protection of 
the product to be at least one-third of 
its claimed sun protection (UVB) value 
(aka ‘broad- spectrum protection’), but still 
break down after two hours or irradiation. 
Of those products ‘Colipa tested’ locally, 
one provided no protection after two hours 
of irradiation, and all broke down to some 
degree. In sharp contrast, sunscreens in EU 
countries have to provide much longer-
lasting and (better) UVA co-protection. 
Meet deadline or we 
withdraw endorsement – 
Cansa  
The Pretoria-based laboratory, Future 
Cosmetics (whose clients include the leading 
local sunscreen brand trio), insisted that 
Cansa sign a contract that its test results 
remain confidential. This prevented Cansa 
from going public and forced it to privately 
approach manufacturers on an individual 
basis, proposing a March 2013 deadline to 
re-formulate their products – or have Cansa 
withdraw its sales-boosting endorsement 
(printed on the labelling). The South African 
sunblock standard (SANS 1557: 2009) is 
considered insufficient, being based on what 
is known as the ‘Boots standard’. Boots is a 
European cosmetic scientist who developed 
the eponymous test, originally adopted by 
most companies marketing such products. 
The Boots-rated one-star products have 
the lowest ratio of UVA-to-UVB protection 
and five-star, the highest. The difference 
between the ‘old’ Boots test and the latest 
Colipa test is the irradiation requirement to 
indicate the levels of UVA protection and the 
cream’s overall stability.There is also no local 
law enforcing compliance to any standard 
and it is left to the Cosmetics, Toiletries 
and Fragrances Association (CTFA) to self-
regulate (its board is dominated by industry 
players).
When it was put (by Noseweek) to Heibrie 
le Roux, CEO of Future Cosmetics, that by 
withholding the information from the public, 
her company was potentially putting scores 
of lives at risk, she snapped: ‘I don’t have to 
talk to you!’ Once the full potential impact 
was sketched for her as follows: ‘For the 
next summer, perhaps two, people are going 
to be buying and using sunscreens on their 
children at the beach, at school sports events, 
confident they are providing the necessary 
protection. You know better, but won’t tell 
them?’, she added the following:‘That’s how 
we do business with all our customers. It 
would not be ethical of me to give you any 
information about our research; you are not 
our customer.’ She then terminated the call. 
Commercial conundrum
Izindaba subsequently learnt that Le Roux’s 
company spent a quarter of a million rand 
on the testing and risked closing its doors 
for business had she ‘blown the whistle’ 
on her clients. This arguably shifts the 
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ethical onus for disclosure (and adjustment 
to the improved five-year-old scientific 
standard) strongly towards local sunblock 
manufacturers and distributors.
Sunscreens produced by Creighton 
Products at its factory in New Germany, 
KwaZulu-Natal, feature large on the 
confidential list of products found wanting 
in the tests commissioned by Cansa. In 
addition to manufacturing products under its 
own brand name, Island Tribe, the company 
supplies house-branded products specially 
packaged for various major chain stores 
including Spar, Clicks, DisChem, Pick n Pay 
and Mr Price. Creighton’s website boasts that 
each of these house brands achieved a 10% 
market share in their respective stores in the 
first year of trading.
The company’s marketing director, Mike 
Arthur, said the first they knew of the Colipa 
standard being promoted by Cansa was in 
March this year when they were invited to 
a meeting where Cansa presented a paper 
on the subject. ‘We have been made to look 
bad, but our current certificates, based on 
tests conducted by Medunsa’s laboratory 
– one of only two local laboratories that 
do these tests – rated our broad-spectrum 
ratios as five-star.’ However, he admitted 
that the Boots standard was used, not the 
Colipa standard. Arthur said he had ‘no 
knowledge’ of how reliable the (Colipa) 
tests were, but admitted that Creighton had 
its work cut out to meet the March 2013 
deadline set by Cansa. Products would 
need to be reformulated with the more 
expensive ingredients required to block 
out UVA rays  available only from major 
multinational suppliers, and each cream 
would then have to be re-tested – at a cost 
of R40 000 per test. 
Dermatologists worried
Dr Dagmar Whitaker, Cape Town 
dermatologist and chairman of the 
Melanoma Society of SA, says the Western 
Cape has perhaps the highest incidence of 
malignant melanoma in the world (similar 
to that of Australia). ‘To date we do not have 
accurate statistics, but the estimated figure 
for the Cape in 2009 was 69 new cases per 
year per population of 100 000 Caucasians. 
Australia has an incidence rate of 65 per 100 
000. This translates to a prediction that 1 in 1 
429 people will be diagnosed with malignant 
melanoma this year. Compare this with the 
figures for the years 1990 - 1995 and you 
find the incidence has trebled over the past 
20 years. Clearly something needs to be 
done urgently to address the risk factors and 
reverse this trend.’ Using an effective, long-
lasting broad-spectrum sunscreen would be 
one such essential precaution.
Dr Carl Albrecht, the pharmacologist/
biochemist who heads Cansa’s research arm, 
told Izindaba that the CTFA decided this 
July to develop a ‘better test than Colipa’. 
It was working on specifications using the 
Colipa-standard testing equipment exclusive 
to Future Cosmetics. The CTFA committee 
overseeing the project was being chaired by 
Ms Heibrie le Roux. ‘I’m told she’s committed 
to it becoming the order of the day in South 
Africa,’ he added. In spite of three messages 
being left with her secretary, the second of 
which outlined the subject matter, Ms Le 
Roux did not return Izindaba’s calls.
Cansa intends to post each sunblock 
product that passes their minimum-
standard Colipa test on its website as and 
when it becomes available next year.1 All 
these products will bear a newly designed 
Cansa logo to distinguish them from those 
it previously endorsed. In the meantime 
Cansa’s advice to daily sun-lovers is to apply 
the highest rated broad-spectrum lotion 
every two hours while wearing the most 
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Of those products ‘Colipa 
tested’ locally, one provided no 
protection after two hours of 
irradiation, and all broke down 
to some degree. In sharp contrast, 
sunscreens in EU countries have 
to provide much longer-lasting 
and (better) UVA co-protection. 
The company’s marketing 
director, Mike Arthur, said the 
first they knew of the Colipa 
standard being promoted by 
Cansa was in March this year 
when they were invited to a 
meeting where Cansa presented a 
paper on the subject. 
